• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与冠状动脉疾病治疗相关的成本和效益。

Costs and benefits associated with treatment for coronary artery disease.

作者信息

Charles E D, Wayne J B, Oberman A, Reed B A, Haynie C, Kouchoukos N T, Rogers W J, Russell R O

出版信息

Circulation. 1982 Nov;66(5 Pt 2):III87-90.

PMID:6812983
Abstract

Direct and indirect costs of medical and of surgical treatment are presented for patients entered into the Birmingham portion of the Coronary Artery Surgery Study. For comparison, similar results are shown for the Birmingham portion of the national Cooperative Unstable Angina Study. In the Unstable Angina Study, mean inpatient costs at the end of 1 year in the study were $6867 for medical therapy, $10,574 for surgical therapy and $23,045 for those who failed medical therapy and required late surgery. A stepwise multiple regression analysis shows that the single best predictor of cost was the number of myocardial infarctions that the patient had while in the study. A discriminant-function analysis identified 85% of the medical patients who required late surgery. A significantly lower proportion of surgical than medical patients returned to work. Total inpatient costs for patients in the Coronary Artery Surgery Study (i.e, patients with stable angina) were $3432, $11,100 and $13,554 for medical, surgical and late surgical patients, respectively, for the first year in the study. There was no significant difference in the percentage of medical and surgical patients who were working at the end of 1 year. According to their own perceptions, the surgical group was in the best and the late surgical group in the worst health.

摘要

本文呈现了冠状动脉手术研究中伯明翰地区患者的内科及外科治疗的直接和间接成本。作为对比,还展示了全国不稳定型心绞痛合作研究中伯明翰地区的类似结果。在不稳定型心绞痛研究中,研究结束时内科治疗患者的平均住院费用为6867美元,外科治疗患者为10574美元,内科治疗失败且需后期手术的患者为23045美元。逐步多元回归分析表明,成本的最佳单一预测指标是患者在研究期间发生心肌梗死的次数。判别函数分析识别出了85%需要后期手术的内科患者。与内科患者相比,返回工作岗位的外科患者比例显著更低。冠状动脉手术研究(即稳定型心绞痛患者)中患者第一年的住院总费用,内科、外科及后期外科患者分别为3432美元、11100美元和13554美元。在研究结束时仍在工作的内科和外科患者比例没有显著差异。根据他们自己的认知,外科组健康状况最佳,后期外科组最差。

相似文献

1
Costs and benefits associated with treatment for coronary artery disease.与冠状动脉疾病治疗相关的成本和效益。
Circulation. 1982 Nov;66(5 Pt 2):III87-90.
2
Relative cost comparison of treatments for coronary artery disease: the First Year Follow-Up of MASS II Study.冠心病治疗的相对成本比较:MASS II研究的第一年随访
Circulation. 2003 Sep 9;108 Suppl 1:II21-3. doi: 10.1161/01.cir.0000087381.98299.7b.
3
Medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease.随机接受血管成形术或搭桥手术治疗多支冠状动脉疾病10至12年后的医疗成本和生活质量。
Circulation. 2004 Oct 5;110(14):1960-6. doi: 10.1161/01.CIR.0000143379.26342.5C. Epub 2004 Sep 27.
4
Cost analysis of aprotinin for coronary artery bypass patients: analysis of the randomized trials.冠状动脉搭桥手术患者使用抑肽酶的成本分析:随机试验分析
Ann Thorac Surg. 2004 Feb;77(2):635-42; discussion 642-3. doi: 10.1016/j.athoracsur.2003.06.008.
5
Cost-effectiveness of invasive versus medical management of elderly patients with chronic symptomatic coronary artery disease. Findings of the randomized trial of invasive versus medical therapy in elderly patients with chronic angina (TIME).老年慢性症状性冠状动脉疾病患者侵入性治疗与药物治疗的成本效益。老年慢性心绞痛患者侵入性治疗与药物治疗随机试验(TIME)的结果。
Eur Heart J. 2004 Dec;25(24):2195-203. doi: 10.1016/j.ehj.2004.09.013.
6
Acute coronary syndromes in Europe: 1-year costs and outcomes.欧洲急性冠状动脉综合征:1年的成本与结局
Curr Med Res Opin. 2007 Mar;23(3):495-503. doi: 10.1185/030079906X167462.
7
[Economic evaluation of different treatment strategies in patients with stable angina pectoris or asymptomatic myocardial ischemia on basis of results from the Asymptomatic-Cardiac-Ischemia Pilot study (ACIP)].基于无症状性心肌缺血初步研究(ACIP)结果对稳定型心绞痛或无症状性心肌缺血患者不同治疗策略的经济学评估
Med Klin (Munich). 2000 Jan 15;95(1):1-13.
8
[Cost-effectiveness analysis of an invasive therapeutic approach to coronary disease].[冠心病侵入性治疗方法的成本效益分析]
Schweiz Med Wochenschr. 1996 Sep 28;126(39):1661-4.
9
[Cost-effectiveness of coronary angioplasty procedures in Poland].
Kardiol Pol. 2004 Jul;61(7):42-7; discussion 48.
10
Clinical and economic outcomes of multivessel coronary stenting compared with bypass surgery: a single-center US experience.多支冠状动脉支架置入术与搭桥手术的临床和经济结果比较:美国单中心经验
Am Heart J. 2003 Feb;145(2):334-42. doi: 10.1067/mhj.2003.38.

引用本文的文献

1
Quality of life among patients post-myocardial infarction at baseline in the Survival and Ventricular Enlargement (SAVE) trial.
Qual Life Res. 1994 Apr;3(2):111-9. doi: 10.1007/BF00435254.